These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8737241)

  • 1. The effect of fumonisin B1 on developing chick embryos: correlation between de novo sphingolipid biosynthesis and gross morphological changes.
    Zacharias C; van Echten-Deckert G; Wang E; Merrill AH; Sandhoff K
    Glycoconj J; 1996 Apr; 13(2):167-75. PubMed ID: 8737241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
    Merrill AH; van Echten G; Wang E; Sandhoff K
    J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
    Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH
    J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme.
    Wang E; Norred WP; Bacon CW; Riley RT; Merrill AH
    J Biol Chem; 1991 Aug; 266(22):14486-90. PubMed ID: 1860857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity.
    Riley RT; Hinton DM; Chamberlain WJ; Bacon CW; Wang E; Merrill AH; Voss KA
    J Nutr; 1994 Apr; 124(4):594-603. PubMed ID: 8145083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.
    Tsunoda M; Sharma RP; Riley RT
    J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells.
    Yoo HS; Norred WP; Wang E; Merrill AH; Riley RT
    Toxicol Appl Pharmacol; 1992 May; 114(1):9-15. PubMed ID: 1585377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subchronic toxic effects of Fusarium moniliforme and fumonisin B1 in rats and mice.
    Voss KA; Riley RT; Bacon CW; Chamberlain WJ; Norred WP
    Nat Toxins; 1996; 4(1):16-23. PubMed ID: 8680749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the reproductive effects of Fusarium moniliforme culture material in rats and the biodistribution of [14C] fumonisin B1 in pregnant rats.
    Voss KA; Bacon CW; Norred WP; Chapin RE; Chamberlain WJ; Plattner RD; Meredith FI
    Nat Toxins; 1996; 4(1):24-33. PubMed ID: 8680750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins.
    Riley RT; Wang E; Schroeder JJ; Smith ER; Plattner RD; Abbas H; Yoo HS; Merrill AH
    Nat Toxins; 1996; 4(1):3-15. PubMed ID: 8680751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.
    Yoo HS; Norred WP; Showker J; Riley RT
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):211-8. PubMed ID: 8658522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
    He Q; Suzuki H; Sharma N; Sharma RP
    Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of fumonisin B1-producing and fumonisin B1-nonproducing Fusarium moniliforme isolates are similar: fumonisins B2 and B3 cause hepato- and nephrotoxicity in rats.
    Voss KA; Plattner RD; Riley RT; Meredith FI; Norred WP
    Mycopathologia; 1998; 141(1):45-58. PubMed ID: 9725030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme.
    Wang E; Ross PF; Wilson TM; Riley RT; Merrill AH
    J Nutr; 1992 Aug; 122(8):1706-16. PubMed ID: 1640265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fumonisin toxicity and sphingolipid biosynthesis.
    Merrill AH; Wang E; Vales TR; Smith ER; Schroeder JJ; Menaldino DS; Alexander C; Crane HM; Xia J; Liotta DC; Meredith FI; Riley RT
    Adv Exp Med Biol; 1996; 392():297-306. PubMed ID: 8850625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs.
    Riley RT; An NH; Showker JL; Yoo HS; Norred WP; Chamberlain WJ; Wang E; Merrill AH; Motelin G; Beasley VR
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):105-12. PubMed ID: 8430417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of sphingolipid metabolism in non-human primates consuming diets of fumonisin-containing Fusarium moniliforme culture material.
    Shephard GS; van der Westhuizen L; Thiel PG; Gelderblom WC; Marasas WF; van Schalkwyk DJ
    Toxicon; 1996 May; 34(5):527-34. PubMed ID: 8783447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The toxicity of fumonisin B1, B2, and B3, individually and in combination, in chicken embryos.
    Henry MH; Wyatt RD
    Poult Sci; 2001 Apr; 80(4):401-7. PubMed ID: 11297276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies).
    Natl Toxicol Program Tech Rep Ser; 2001 Dec; (496):1-352. PubMed ID: 11852482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fumonisin B(1) induces apoptosis in LLC-PK(1) renal epithelial cells via a sphinganine- and calmodulin-dependent pathway.
    Kim MS; Lee DY; Wang T; Schroeder JJ
    Toxicol Appl Pharmacol; 2001 Oct; 176(2):118-26. PubMed ID: 11601888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.